QUIA PHARMA AB Logo

QUIA PHARMA AB

QUIA | ST

Overview

Corporate Details

ISIN(s):
SE0020678159
LEI:
967600JUP7EI6X9D2Z44
Country:
Sweden
Address:
Virdings Allé 32 B, 754 50 Uppsala
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

QUIA PHARMA AB is a pharmaceutical development company focused on its proprietary and patented drug delivery platform, Uni-Qleaver®. This platform is based on a unique, releasable pegylation technology designed to create improved and patentable versions of both new and existing, approved drugs. The company engages in the research, development, and commercialization of a pipeline of enhanced medicines, aiming to improve the efficacy and properties of pharmaceutical treatments.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for QUIA PHARMA AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all QUIA PHARMA AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for QUIA PHARMA AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
Plantarc Bio Ltd. Logo
Agritech firm using gene discovery & editing to improve crop yield, resilience, and pest control.
Israel PLNT
POLAREAN IMAGING PLC Logo United States of America POLX
Poltreg S.A. Logo
Develops T-regulatory cell (Treg) therapies for autoimmune diseases like diabetes and MS.
Poland PTG
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
Poxel Logo
Biopharma developing treatments for metabolic diseases like NASH, with a marketed drug for diabetes.
France POXEL
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Psych Capital Plc Logo
Develops psilocybin-based therapies for anorexia nervosa and other mental health conditions.
United Kingdom PSY
Pure Biologics S.A. Logo
Develops novel antibody and aptamer drugs for immuno-oncology and autoimmunity.
Poland PUR